協和コンサルタンツの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/08 | 3,305 | 3,345 | 3,280 | 3,345 | +40 | +1.2% | 700 |
| 2022/11/07 | 3,285 | 3,305 | 3,280 | 3,305 | +5 | +0.2% | 800 |
| 2022/11/04 | 3,275 | 3,300 | 3,270 | 3,300 | -45 | -1.3% | 500 |
| 2022/11/02 | 3,300 | 3,345 | 3,265 | 3,345 | +65 | +2% | 600 |
| 2022/11/01 | 3,355 | 3,355 | 3,280 | 3,280 | -40 | -1.2% | 300 |
| 2022/10/31 | 3,340 | 3,340 | 3,320 | 3,320 | -10 | -0.3% | 500 |
| 2022/10/28 | 3,330 | 3,330 | 3,330 | 3,330 | - | - | 200 |
| 2022/10/27 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/10/26 | 3,375 | 3,375 | 3,300 | 3,300 | -75 | -2.2% | 1,800 |
| 2022/10/25 | 3,375 | 3,375 | 3,370 | 3,375 | ±0 | ±0% | 700 |
| 2022/10/24 | 3,375 | 3,375 | 3,375 | 3,375 | ±0 | ±0% | 100 |
| 2022/10/21 | 3,330 | 3,375 | 3,330 | 3,375 | +145 | +4.5% | 600 |
| 2022/10/20 | 3,375 | 3,375 | 3,230 | 3,230 | -145 | -4.3% | 1,400 |
| 2022/10/19 | 3,395 | 3,410 | 3,350 | 3,375 | -65 | -1.9% | 1,100 |
| 2022/10/18 | 3,420 | 3,490 | 3,380 | 3,440 | -15 | -0.4% | 1,900 |
| 2022/10/17 | 3,500 | 3,540 | 3,450 | 3,455 | -115 | -3.2% | 1,500 |
| 2022/10/14 | 3,415 | 3,645 | 3,415 | 3,570 | +180 | +5.3% | 4,000 |
| 2022/10/13 | 3,710 | 3,725 | 3,390 | 3,390 | -305 | -8.3% | 6,800 |
| 2022/10/12 | 3,715 | 3,750 | 3,695 | 3,695 | -70 | -1.9% | 300 |
| 2022/10/11 | 3,800 | 3,875 | 3,755 | 3,765 | -65 | -1.7% | 1,600 |
| 2022/10/07 | 3,800 | 3,930 | 3,765 | 3,830 | +75 | +2% | 2,800 |
| 2022/10/06 | 3,675 | 3,825 | 3,660 | 3,755 | +80 | +2.2% | 6,800 |
| 2022/10/05 | 3,690 | 3,720 | 3,650 | 3,675 | -15 | -0.4% | 800 |
| 2022/10/04 | 3,700 | 3,750 | 3,690 | 3,690 | -35 | -0.9% | 900 |
| 2022/10/03 | 3,725 | 3,725 | 3,655 | 3,725 | ±0 | ±0% | 1,100 |
| 2022/09/30 | 3,790 | 3,790 | 3,620 | 3,725 | -55 | -1.5% | 1,100 |
| 2022/09/29 | 3,665 | 3,830 | 3,605 | 3,780 | +130 | +3.6% | 1,500 |
| 2022/09/28 | 3,810 | 3,810 | 3,620 | 3,650 | -160 | -4.2% | 2,300 |
| 2022/09/27 | 3,810 | 3,810 | 3,810 | 3,810 | +5 | +0.1% | 100 |
| 2022/09/26 | 3,955 | 3,955 | 3,685 | 3,805 | -150 | -3.8% | 2,100 |
| 2022/09/22 | 3,965 | 4,005 | 3,850 | 3,955 | +60 | +1.5% | 4,100 |
| 2022/09/21 | 3,625 | 4,170 | 3,625 | 3,895 | +200 | +5.4% | 6,600 |
| 2022/09/20 | 3,790 | 3,890 | 3,695 | 3,695 | -25 | -0.7% | 1,200 |
| 2022/09/16 | 4,135 | 4,135 | 3,720 | 3,720 | -345 | -8.5% | 9,700 |
| 2022/09/15 | 4,315 | 4,315 | 4,065 | 4,065 | -215 | -5% | 5,800 |
| 2022/09/14 | 4,500 | 4,540 | 4,160 | 4,280 | -340 | -7.4% | 19,100 |
| 2022/09/13 | 3,930 | 4,620 | 3,930 | 4,620 | +700 | +17.9% | 33,700 |
| 2022/09/12 | 3,900 | 3,945 | 3,850 | 3,920 | -25 | -0.6% | 2,900 |
| 2022/09/09 | 4,100 | 4,100 | 3,935 | 3,945 | -130 | -3.2% | 3,000 |
| 2022/09/08 | 4,175 | 4,175 | 3,965 | 4,075 | -100 | -2.4% | 2,300 |
| 2022/09/07 | 4,185 | 4,185 | 4,000 | 4,175 | -15 | -0.4% | 3,600 |
| 2022/09/06 | 4,300 | 4,360 | 4,145 | 4,190 | -55 | -1.3% | 2,900 |
| 2022/09/05 | 4,260 | 4,530 | 4,190 | 4,245 | -110 | -2.5% | 6,300 |
| 2022/09/02 | 4,510 | 4,510 | 4,285 | 4,355 | -40 | -0.9% | 7,300 |
| 2022/09/01 | 4,795 | 4,845 | 4,310 | 4,395 | -470 | -9.7% | 17,700 |
| 2022/08/31 | 5,100 | 5,500 | 4,780 | 4,865 | -415 | -7.9% | 29,300 |
| 2022/08/30 | 4,535 | 5,280 | 4,535 | 5,280 | +700 | +15.3% | 65,900 |
| 2022/08/29 | 4,700 | 5,200 | 4,450 | 4,580 | -305 | -6.2% | 37,600 |
| 2022/08/26 | 5,020 | 5,210 | 4,700 | 4,885 | -235 | -4.6% | 25,400 |
| 2022/08/25 | 5,200 | 5,450 | 4,640 | 5,120 | +195 | +4% | 86,900 |
601～
650
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「協和コンサ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和コンサ | 603,000円 | +0.5% | +8.0% | - | - | - |
|
建設コンサル中堅。地公体に加え、防衛省案件にも実績多い。調査、設計から施工管理まで実施 |
| ブラス | 62,200円 | +8.3% | +25.2% | 1.29% | 9.01倍 | 0.83倍 |
|
直営の完全貸し切り型ゲストハウスでのウェディング事業を展開。東海地盤、地域拡大に意欲 |
| 笑美面 | 175,300円 | - | - | 0.00% | 15.85倍 | 4.93倍 |
|
老人ホーム等の入居検討者に施設を紹介するマッチング事業が主。ホーム運営向けコンサルも |
| 旅工房 | 17,500円 | +1.5% | - | 0.00% | - | 1.63倍 |
|
ネット専業旅行会社。地域専門担当者による提案販売に強み。親会社は同業のアドベンチャー |
| 総医研 | 13,200円 | -2.1% | - | 0.00% | - | 0.57倍 |
|
抗疲労食品・飲料の直販と中国ＥＣ主体の化粧品販売が収益柱。健保関連や医薬品臨試受託も |
市場注目の銘柄
該当銘柄がありません
チャート関連のコラム
